Journal of Critical Care
Volume 24, Issue 4 , Pages 535-544 , December 2009

State of the art: Sedation concepts with volatile anesthetics in critically Ill patients

References 

  1. Martin J, Parsch A, Franck M, et al. Practice of sedation and analgesia in German intensive care units: results of a national survey. Crit Care. 2005;9:R117–R123
  2. Breen D, Karabinis A, Malbrain M, et al. Decreased duration of mechanical ventilation when comparing analgesia-based sedation using remifentanil with standard hypnotic-based sedation for up to 10 days in intensive care unit patients: a randomised trial. Crit Care. 2005;9(3):R200–R210
  3. Cremer OL, Moons KG, Bouman EA, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet. 2001;357(9250):117–118
  4. Burns AM, Shelly MP, Park GR. The use of sedative agents in critically ill patients. Drugs. 1992;43(4):507–515
  5. Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med. 1998;26(5):947–956
  6. Kress JP, Hall JB. Delirium and sedation. Crit Care Clin. 2004;20(3):419–433
  7. Gupta A, Stierer T, Zuckerman R, et al. Comparison of recovery profile after ambulatory anesthesia with propofol, isoflurane, sevoflurane and desflurane: a systematic review. Anesth Analg. 2004;98(3):632–641
  8. Kehl F, Smul T, Lange M, et al. Organprotektion durch volatile Anästhetika. Anästhesiologie und Intensivmedizin. 2004;11(12):491–507
  9. Tassani-Prell P, Wiesner G. Einbau von Narkosegasvaporen in der Herz-Lungen- Maschine. Anästh Intensivmed. 2005;46:146–155
  10. Engelhard K, Werner C, Reeker W. Desflurane and isoflurane improve neurologic outcome after incomplete cerebral ischemia in rats. Br J Anaesth. 1999;83:415–421
  11. Werner C, Mollenberg O, Kochs E, et al. Sevoflurane improves neurological outcome after incomplete cerebral ischaemia in rats. Br J Anaessth. 1985;75:756–760
  12. Kehl F, Payne R, Roewer N, et al. Sevoflurane-induced preconditioning of rat brain in vitro and the role of KATP channels. Brain Res. 2004;1021:76–81
  13. Lehmann G, Opitz A. Technische Vorraussetzungen für die Langzeitsedierung mit volatilen Anästhetika (Isofluran). In:  Opitz A editors. Methoden der Analgosedierung in der Intensivmedizin. vol. 46:Bielefeld: Bethel-Verlag; 1989;p. 124–129
  14. Meiser A, Sirtl C, Bellgardt M, et al. Desflurane compared with propofol for postoperative sedation in the intensive care unit. Br J Anaesth. 2003;90(3):273–280
  15. Perhag L, Reinstrup P, Thomasson R, et al. The Reflector: a new method for saving anaesthetic vapours. Br J Anaesth. 2000;85(3):482–486
  16. Jung C, Granados M, Marsol P, et al. Use of sevoflurane sedation by the AnaConDa™((R)) device as an adjunct to extubation in a pediatric burn patient. Burns. 2007;
  17. Sackey PV, Martling CR, Radell PJ. Three cases of PICU sedation with isoflurane delivered by the ‘AnaConDa™’. Paediatr Anaesth. 2005;15(10):879–885
  18. Meiser A, Laubenthal H. Inhalational anaesthetics in the ICU: theory and practice of inhalational sedation in the ICU, economics, risk-benefit. Best Pract Res Clin Anaesthesiol. 2005;19(3):523–538
  19. NIOSH . Criteria for a recommended standard: occupational exposure to anesthetic gases and vapors. Cincinnati (Ohio): United States Department of Health, Education, and Welfare; 1977;
  20. DGAI/BDA (Hrsg.): Umsetzung der Gefahrstoffverordnung Entschlieβungen-Empfehlungen-Vereinbarungen-Leitlinien: 365-372. 4.Auflage (2000)
  21. Sackey PV, Martling CR, Nise G, et al. Ambient isoflurane pollution and isoflurane consumption during intensive care unit sedation with the Anesthetic Conserving Device. Crit Care Med. 2005;33(3):585–590
  22. Inghausen JG: Gutachten Sicherheit des NovaSorb-Filtersystem bei der Verwendung des Narkosegas-Rezirkulationssystems "AnaConDa™". In. Düsseldorf: Industrie- und Handelskammer zu Düsseldorf, Sachverständiger für Narkose-, Beatmungsgeräte und Infusionstechnik; 2005: 1-6.
  23. Hoerauf K, Koller C, Vescia F, et al. Exposure of intensive care personnel to isoflurane in long-term sedation. Anasthesiol Intensivmed Notfallmed Schmerzther. 1995;30(8):483–487
  24. Korth M, Opitz A. Erste klinische Erfahrungen in der Langzeitsedierung mit Isofluran. In:  Opitz A editors. Methoden der Analgosedierung in der Intensivmedizin. vol. 46:Braunschweig: Bethel-Verlag; 1989;p. 130–138
  25. Stuttmann R, Pillukat T, Müller-Gorges M, et al. Sedierung mit Isofluran unter pulmonalen und hämodynamischen Aspekten. In:  Opitz A editors. Methoden der Analgosedierung auf der Intensivstation. vol. 46:Braunschweig: Bethel-Verlag; 1989;p. 139–146
  26. Kong KL, Willatts SM, Prys-Roberts C. Isoflurane compared with midazolam for sedation in the intensive care unit. BMJ. 1989;298(6683):1277–1280
  27. Spencer EM, Willatts SM. Inorganic fluoride and prolonged anesthesia. Anesth Analg. 1990;71(1):103–104
  28. Spencer EM, Willatts SM. Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety. Intensive Care Med. 1992;18(7):415–421
  29. Millane TA, Bennett ED, Grounds RM. Isoflurane and propofol for long-term sedation in the intensive care unit. A crossover study. Anaesthesia. 1992;47(9):768–774
  30. Arnold JH, Truog RD, Rice SA. Prolonged administration of isoflurane to pediatric patients during mechanical ventilation. Anesth Analg. 1993;76(3):520–526
  31. Appleyard TN, Hewlett A, Konieczko K, et al. Isoflurane sedation—a multi-centre study of 55 patients. Clin Intensive Care. 1994;5:212–216
  32. Tanigami H, Yahagi N, Kumon K, et al. Long-term sedation with isoflurane in postoperative intensive care in cardiac surgery. Artif Organs. 1997;21(1):21–23
  33. Bierman MI, Brown M, Muren O, et al. Prolonged isoflurane anesthesia in status asthmaticus. Crit Care Med. 1986;14(9):832–833
  34. Revell S, Greenhalgh D, Absalom SR, et al. Isoflurane in the treatment of asthma. Anaesthesia. 1988;43(6):477–479
  35. Kofke WA, Snider MT, Young RS, et al. Prolonged low flow isoflurane anesthesia for status epilepticus. Anesthesiology. 1985;62(5):653–656
  36. Johnston RG, Noseworthy TW, Friesen EG, et al. Isoflurane therapy for status asthmaticus in children and adults. Chest. 1990;97(3):698–701
  37. Breheny FX, Kendall PA. Use of isoflurane for sedation in intensive care. Crit Care Med. 1992;20(7):1062–1064
  38. Osborne MA, Eddleston JM, McNicoll W. Inorganic fluoride concentration after long- term sedation with isoflurane. Intensive Care Med. 1996;22(7):677–682
  39. Mirsattari SM, Sharpe MD, Young GB. Treatment of refractory status epilepticus with inhalational anesthetic agents isoflurane and desflurane. Arch Neurol. 2004;61(8):1254–1259
  40. Shankar V, Churchwell KB, Deshpande JK. Isoflurane therapy for severe refractory status asthmaticus in children. Intensive Care Med. 2006;32(6):927–933
  41. Howie AF, Spencer E, Beckett GJ. Aspartate aminotransferase, alanine aminotransferase, and glutathione transferase in plasma during and after sedation by low-dose isoflurane or midazolam. Clin Chem. 1992;38(4):476–479
  42. Thompson K, Wisenberg G, Sykes J, et al. Similar long-term cardiovascular effects of propofol or isoflurane anesthesia during ischemia/reperfusion in dogs. Can J Anaesth. 2002;49(9):978–985
  43. Sackey PV, Radell PJ, Granath F, et al. Bispectral index as a predictor of sedation depth during isoflurane or midazolam sedation in ICU patients. Anaesth Intensive Care. 2007;35(3):348–356
  44. Nickel EA, Benken I, Bartels U, et al. AnaConDa™ as last resort treatment. Case report of a chronic obstructive pulmonary disease. Anaesthesist. 2007;56(6):587–591
  45. Berton J, Sargentini C, Nguyen JL, et al. AnaConDa™ reflection filter: bench and patient evaluation of safety and volatile anesthetic conservation. Anesth Analg. 2007;104(1):130–134
  46. Tempia A, Olivei M, Calza E. The anesthetic conserving device compared with conventional circle system used under different flow conditions for inhaled anesthesia. Anesth Analg. 2003;96:1056–1061
  47. Sackey PV, Martling CR, Granath F, et al. Prolonged isoflurane sedation of intensive care unit patients with the Anesthetic Conserving Device. Crit Care Med. 2004;32(11):2241–2246
  48. Hanafy MA. Clinical evaluation of inhalational sedation following coronary artery bypass grafting. Eg J Anaesth. 2005;21:237–242
  49. Soukup J, Schärff K, Kubosch K, et al. Sedierung mit volatilen Anästhetika auf der Intensivstation: Technische Umsetzung und derzeitige Erfahrungen. Intensiv- und Notfallbehandlung. 2006;32(1):29–36
  50. Röhm KD, Wolf MW, Schöllhorn T, et al. Short-term sevoflurane sedation using the Anaesthetic Conserving Device after cardiothoracic surgery. Intensive Care Med. 2008;34(9):1683–1689
  51. Satoh M, Abe M, Inoue S, et al. [Drug-induced side effects in a patient with status asthmaticus treated with long-term isoflurane inhalation]. Masui. 2002;51(4):418–421
  52. Miyagi T, Gushima Y, Matsumoto T, et al. Prolonged isoflurane anesthesia in a case of catastrophic asthma. Acta Paediatr Jpn. 1997;39(3):375–378
  53. Takeyama K, Takaya T, Takiguchi M, et al. [A case of status asthmatics relieved by long-term inhalation of isoflurane]. Masui. 1995;44(11):1559–1562
  54. Spencer EM, Willatts SM, Prys-Roberts C. Plasma inorganic fluoride concentrations during and after prolonged (greater than 24 h) isoflurane sedation: effect on renal function. Anesth Analg. 1991;73(6):731–737

PII: S0883-9441(09)00006-9

doi: 10.1016/j.jcrc.2009.01.003

Journal of Critical Care
Volume 24, Issue 4 , Pages 535-544 , December 2009

Article Tools

* Image Usage & Resolution